These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1159819)

  • 21. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
    Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
    Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic activation of aromatic amines and azo dyes.
    Bartsch H
    IARC Sci Publ; 1981; (40):13-30. PubMed ID: 6799396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
    Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylation, deacetylation and acyltransfer.
    King CM; Glowinski IB
    Environ Health Perspect; 1983 Mar; 49():43-50. PubMed ID: 6131820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation, metabolic activation by N, O-acyltransfer, and hydrolysis of N-acyl-N-arylamine derivatives.
    King CM; Weber WW
    Natl Cancer Inst Monogr; 1981 Dec; (58):117-22. PubMed ID: 7341969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species.
    Tatsumi K; Kitamura S; Amano H; Ueda K
    Cancer Res; 1989 Apr; 49(8):2059-64. PubMed ID: 2702648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids.
    Kolanczyk RC; Gutmann HR; Rutks IR
    Chem Res Toxicol; 1992; 5(2):274-9. PubMed ID: 1643258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair synthesis of DNA induced by the urinary N-hydroxy metabolites of carcinogenic arylamines in urothelial cells of susceptible species.
    Wang CY; Morton KC; Lee MS
    Cancer Res; 1985 Jan; 45(1):221-5. PubMed ID: 3965133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids.
    Kolanczyk RC; Rutks IR; Gutmann HR
    Chem Res Toxicol; 1991; 4(2):187-94. PubMed ID: 1782347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells.
    Swaminathan S; Reznikoff CA
    Cancer Res; 1992 Jun; 52(12):3286-94. PubMed ID: 1375866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analogues of N-hydroxy-4-acetylaminobiphenyl as substrates and inactivators of hamster hepatic acetyltransferases.
    Hanna PE; el-Ghandour AM; McCormack ME
    Xenobiotica; 1990 Jul; 20(7):739-51. PubMed ID: 2238707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the aryl group on the reaction of glucuronides of N-arylacethydroxamic acids with polynucleotides.
    Irving CC
    Cancer Res; 1977 Feb; 37(2):524-8. PubMed ID: 832276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases.
    Butler MA; Guengerich FP; Kadlubar FF
    Cancer Res; 1989 Jan; 49(1):25-31. PubMed ID: 2908851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid hydroperoxide activation of N-hydroxy-N-acetylaminofluorene via a free radical route.
    Floyd RA; Soong LM; Walker RN; Stuart M
    Cancer Res; 1976 Aug; 36(8):2761-7. PubMed ID: 1277186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O-sulfonation of N-hydroxy-2-fluorenylacetamide and 7-hydroxy-N-2-fluorenylacetamide in fetal and placental tissues of humans and guinea pigs.
    Namkung MJ; Zachariah PK; Juchau MR
    Drug Metab Dispos; 1977; 5(3):288-94. PubMed ID: 17528
    [No Abstract]   [Full Text] [Related]  

  • 38. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
    Zieve FJ; Gutmann HR
    Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
    [No Abstract]   [Full Text] [Related]  

  • 40. Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase.
    Elfarra AA; Hanna PE
    J Med Chem; 1985 Oct; 28(10):1453-60. PubMed ID: 4045921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.